My name is Logan Thrasher Collins and I make science fiction into reality.
I’m a futurist, synthetic biologist, author, and innovator. When I was 16, I invented a new antimicrobial protein, OpaL (Overexpressed protein aggregator Lipophilic). Since then, I have developed a bacterial conjugation delivery system for the gene encoding OpaL. My synthetic biology research has been published as a first-author journal article in ACS Biochemistry: “Design of a De Novo Aggregating Antimicrobial Peptide and a Bacterial Conjugation-Based Delivery System.” If you cannot access the full text, please use the following local file instead. In addition, my synthetic biology research has been recognized at numerous venues including TEDxMileHigh, the Intel International Science and Engineering Fair, the International BioGENEius Challenge at the BIO International Convention, the Stockholm International Youth Science Seminar (during which I attended the Nobel Prize ceremonies), and at the American Society for Microbiology General Meeting.
I am bringing my synthetic biology skills to the fields of connectomics and nanotechnology methods for neuroengineering. Currently, I am creating a nanoparticle-based method for structural connectomics and I have received a $26,000 award to develop this technology. So far, I have acquired some very promising proof-of-concept data. I have also written a sole-author editorial journal article on insect brain emulation which has been published in Biological Cybernetics: “The case for emulating insect brains using anatomical ‘wiring diagrams’ equipped with biophysical models of neuronal activity.” If you cannot access the full text, please use the following local file instead. This paper proposes creating biologically realistic simulations of insect brains and details a possible path towards the goal. Furthermore, the international organization NeuroTechX has published my timeline of major breakthroughs in neurotechnology from 2005-2018 (Global Highlights in Neuroengineering).
In addition to research, I also write science fiction and sci-fi poetry. For me, writing is both intrinsically rewarding and helps to stimulate my imagination and shape my scientific endeavors. My writing fuels my science and my science fuels my writing.
My published sci-fi poems include “The Sonata Machine” (Andromeda Spaceways Magazine), “Neuraweb” (Abyss & Apex Magazine), Neuva Shikaga (Altered Reality Magazine), Gorgeous Geometries (Altered Reality Magazine), and cyberjinn (Altered Reality Magazine). Neuraweb has been nominated for the Pushcart Prize and the Rhysling Award. In the realm of fiction, my short story “Relinquish / Metamorph” was published by 365tomorrows and my short story “Queen of the Universe” was published in Aphelion. In addition, my poetry and fiction have been recognized in student-run literary magazines as well as (longer ago) the Scholastic Art and Writing Competition. I am working on publishing several other sci-fi poems as well as flash fiction pieces.
I am an avid autodidact. I have independently studied a wide array of topics such as molecular biology and genetics, applied probability, biochemistry, microbiology, experimental artwork, endocrinology, protein engineering, MATLAB, speculative poetry, graph theory (also see algebraic graph mappings), insect neuroscience (i.e. Drosophila and bees), computational neuroscience, quantum mechanics, topology, medicinal chemistry, nanotechnology (i.e. nanoparticle superlattices and upconversion nanoparticles), techniques in microscopy (i.e. light-sheet and two-photon), wave optics, x-ray physics, and many more. Note that the linked pages do not necessarily represent the entirety of my investigations into the given topic.
My personal philosophy most closely aligns with transhumanism, positive existentialism, rational romanticism, scientism, liberal feminism, socialistic capitalism, technological utopianism, atheism, panpsychism, individualism, and kindness.
I intend to obtain a PhD in bioengineering and research neural interfaces and tools for high-resolution connectomics using synthetic biology and bionanotechnology methods. Although I plan to work in an academic setting, I will collaborate with industry to bring my research to the market. I feel that real-world application is the most important metric for my research. While I also see value in contributing to scientific discourse through publications, my primary goal is to positively impact people’s lives with my inventions.
I am actively working towards making the future the best that it can be. Get your head in the clouds, the future is only limited by the imagination!